353 related articles for article (PubMed ID: 31509622)
1. ANKLE1 N
Tian J; Ying P; Ke J; Zhu Y; Yang Y; Gong Y; Zou D; Peng X; Yang N; Wang X; Mei S; Zhang Y; Wang C; Zhong R; Chang J; Miao X
Int J Cancer; 2020 Jun; 146(12):3281-3293. PubMed ID: 31509622
[TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
3. RNA N
Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
[TBL] [Abstract][Full Text] [Related]
4. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in m6A modification genes are associated with colorectal cancer risk.
Meng Y; Li S; Gu D; Xu K; Du M; Zhu L; Chu H; Zhang Z; Wu Y; Fu Z; Wang M
Carcinogenesis; 2020 Mar; 41(1):8-17. PubMed ID: 31579913
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer.
Wang S; Gao S; Zeng Y; Zhu L; Mo Y; Wong CC; Bao Y; Su P; Zhai J; Wang L; Soares F; Xu X; Chen H; Hezaveh K; Ci X; He A; McGaha T; O'Brien C; Rottapel R; Kang W; Wu J; Zheng G; Cai Z; Yu J; He HH
Gastroenterology; 2022 Apr; 162(4):1183-1196. PubMed ID: 34968454
[TBL] [Abstract][Full Text] [Related]
7. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
9. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
[TBL] [Abstract][Full Text] [Related]
10. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
11. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
12. Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N
Wang S; Gan M; Chen C; Zhang Y; Kong J; Zhang H; Lai M
Cancer Sci; 2021 Aug; 112(8):3243-3254. PubMed ID: 34097350
[TBL] [Abstract][Full Text] [Related]
13. A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population.
Li J; Zou L; Zhou Y; Li L; Zhu Y; Yang Y; Gong Y; Lou J; Ke J; Zhang Y; Tian J; Zou D; Peng X; Chang J; Gong J; Zhong R; Zhou X; Miao X
Mol Carcinog; 2017 Jul; 56(7):1798-1807. PubMed ID: 28218435
[TBL] [Abstract][Full Text] [Related]
14. miR-608 rs4919510 Polymorphism May Affect Susceptibility to Colorectal Cancer by Upregulating
Zhu X; Liu Y; Xu J; Cheng Z; Yu Y; Chu M; Lu X; Yuan W
DNA Cell Biol; 2020 Nov; 39(11):2017-2027. PubMed ID: 33147064
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
16.
Bakshi D; Katoch A; Chakraborty S; Shah R; Sharma B; Bhat A; Verma S; Bhat GR; Nagpal A; Vaishnavi S; Goswami A; Kumar R
Front Genet; 2020; 11():609758. PubMed ID: 33584808
[TBL] [Abstract][Full Text] [Related]
17. Role of MYH polymorphisms in sporadic colorectal cancer in China: a case-control, population-based study.
Yang L; Huang XE; Xu L; Zhou JN; Yu DS; Zhou X; Li DZ; Guan X
Asian Pac J Cancer Prev; 2013; 14(11):6403-9. PubMed ID: 24377541
[TBL] [Abstract][Full Text] [Related]
18. m
Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
[TBL] [Abstract][Full Text] [Related]
19. N
Li Y; He L; Wang Y; Tan Y; Zhang F
Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
[TBL] [Abstract][Full Text] [Related]
20. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
[Next] [New Search]